Mortality risk with preadmission metformin use in patients with COVID-19 and diabetes: a meta-analysis

Chia Siang Kow; Syed Shahzad Hasan

doi:10.1002/jmv.26498

Mortality risk with preadmission metformin use in patients with COVID-19 and diabetes: a meta-analysis

Chia Siang Kow, Syed Shahzad Hasan

Research output: Contribution to journal › Letter › peer-review

48 Citations (Scopus)

Abstract

The novel coronavirus disease 2019 (COVID‐19), caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), is currently the biggest threat to the public health and an enormous challenge to the healthcare systems across the world.

Original language	English
Pages (from-to)	695-697
Number of pages	3
Journal	Journal of Medical Virology
Volume	93
Issue number	2
Early online date	9 Sep 2020
DOIs	https://doi.org/10.1002/jmv.26498
Publication status	Published - 1 Feb 2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1002/jmv.26498Licence: Unspecified

Cite this

@article{16ef813984b5462689dcc8ba709278dc,

title = "Mortality risk with preadmission metformin use in patients with COVID-19 and diabetes: a meta-analysis",

abstract = "The novel coronavirus disease 2019 (COVID‐19), caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), is currently the biggest threat to the public health and an enormous challenge to the healthcare systems across the world.",

keywords = "COVID-19, Metformin, Diabetes",

author = "Kow, {Chia Siang} and Hasan, {Syed Shahzad}",

year = "2021",

month = feb,

day = "1",

doi = "10.1002/jmv.26498",

language = "English",

volume = "93",

pages = "695--697",

journal = "Journal of Medical Virology",

issn = "0146-6615",

publisher = "Wiley-Liss Inc.",

number = "2",

}

TY - JOUR

T1 - Mortality risk with preadmission metformin use in patients with COVID-19 and diabetes

T2 - a meta-analysis

AU - Kow, Chia Siang

AU - Hasan, Syed Shahzad

PY - 2021/2/1

Y1 - 2021/2/1

N2 - The novel coronavirus disease 2019 (COVID‐19), caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), is currently the biggest threat to the public health and an enormous challenge to the healthcare systems across the world.

AB - The novel coronavirus disease 2019 (COVID‐19), caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), is currently the biggest threat to the public health and an enormous challenge to the healthcare systems across the world.

KW - COVID-19

KW - Metformin

KW - Diabetes

UR - http://www.scopus.com/inward/record.url?scp=85091682067&partnerID=8YFLogxK

U2 - 10.1002/jmv.26498

DO - 10.1002/jmv.26498

M3 - Letter

VL - 93

SP - 695

EP - 697

JO - Journal of Medical Virology

JF - Journal of Medical Virology

SN - 0146-6615

IS - 2

ER -

Mortality risk with preadmission metformin use in patients with COVID-19 and diabetes: a meta-analysis

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this